Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H4N4O |
Molecular Weight | 136.1115 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1N=CNC2=C1C=NN2
InChI
InChIKey=OFCNXPDARWKPPY-UHFFFAOYSA-N
InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)
Molecular Formula | C5H4N4O |
Molecular Weight | 136.1115 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:03:21 UTC 2023
by
admin
on
Sat Dec 16 18:03:21 UTC 2023
|
Record UNII |
63CZ7GJN5I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1637
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
WHO-VATC |
QM04AA51
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.2
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
NCI_THESAURUS |
C921
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
WHO-VATC |
QM04AA01
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
LIVERTOX |
NBK548098
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
WHO-ATC |
M04AA51
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
WHO-ATC |
M04AA01
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
NDF-RT |
N0000000206
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
NDF-RT |
N0000175698
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
2.3
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
124
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
184856-42-6
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
SUPERSEDED | |||
|
63CZ7GJN5I
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
40279
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
1390
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
6795
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
Allopurinol
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
C224
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
100000091907
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
135401907
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
CHEMBL1467
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
m1541
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | Merck Index | ||
|
39464-14-7
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
SUPERSEDED | |||
|
519
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | RxNorm | ||
|
22767-92-6
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
SUPERSEDED | |||
|
206-250-9
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
101655
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
ALLOPURINOL
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
315-30-0
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
3004
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
SUB05338MIG
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
63CZ7GJN5I
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
ALLOPURINOL
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | Description: A white or almost white, microcrystalline powder; odourless or almost odourless. Solubility: Very slightly soluble in water and in ethanol (~750 g/l) TS and ether R. Category: Xanthine oxidase inhibitor. Storage: Allopurinol should be kept in a well-closed container. Definition: Allopurinol contains not less than 98.0% and not more than 101.0% of C5H4N4O, calculated with reference to the dried substance. | ||
|
1013002
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
1731
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
D000493
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
DTXSID4022573
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY | |||
|
DB00437
Created by
admin on Sat Dec 16 18:03:23 UTC 2023 , Edited by admin on Sat Dec 16 18:03:23 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
In USP/NF not more than 10 ppm of hydrazine is found
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||